Management of hemato-oncology children during covid-19 crisis

The Coronavirus (COVID-19) caused by severe acute respiratory syndrome, coronavirus 2(SARS-CoV-2) The COVID-19 pandemic has had a catastrophic effect on global health About 2% of confirmed cases of COVID-19 were among children aged<18yrs old Children, teens and young adults are at higher risk for severe complication and presentation with multisystem inflammatory dis-ease Management of children with COVID infection is not yet standardized However, cancer children are at potential risk due to immunocompromised status and their management is unknown The immunocompromised children are at risk of severe infection, and they have a high mortality rate Here in this article, we are describing when to suspect COVID infection, how to manage newly diagnosed cancer children and existing patient including bone marrow transplantation and immunosuppression therapy and also blood transfusion policy during COVID pandemic time